Interactive Health Communication for longer, better lives.

One Gene May Be Key to Myeloma

I went to a presentation last night by a guy named James Bond (Jim loves to make 007 jokes).  Jim has been a mm survivor for more than 16 years.

His long term survivor story is in the "survivor stories" link.  

Since his mm diagnosis in 1991, Jim has undergone two autologus bone marrow transplants, one mini allo transplant, thalidomide, velcade, and is now on revlimid. The article linked below made me think of Jim's mm journey.  Jim has taken full advantage of each new conventional mm therapy available.  He undergoes the therapy until it doesn't work anymore for him.  Jim knows his mm will return and he is always on the lookout for the next mm therapy that will give him more time.  David  

"Reducing the activity of the gene by only 50 percent is enough to
kill myeloma cells without compromising other healthy activities, said
scientists reporting in the current issue of Nature.

"This pathway is so critical to the growth of myeloma that,
potentially, if you turn it off, you've found a chink in the armor,"
said Dr. Bart Kamen, executive vice president and chief medical officer
at The Leukemia & Lymphoma Society."

 

 

http://www.healthday.com/...

Post new comment

The content of this field is kept private and will not be shown publicly.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

More information about formatting options

CAPTCHA
Please type in these five (5) letters or numbers to verify you aren't a SPAM Bot!
Image CAPTCHA
Copy the characters (respecting upper/lower case) from the image.